http://www.rxpgnews.com/ Medical News and Information Thu, 23 Oct 2008 14:17:34 PST en-us http://www.rxpgnews.com/hepatitis/Factors_for_developing_IPF_in_Hepatitis_C_patients_123817.shtml Hepatitis There is little or no information on the yearly cumulative incidence and risk factors on the development rate of Idiopathic pulmonary fibrosis in patients with HCV.A research team led by Yasuji Arase from Toranomon Hospital of Japan addresses this, and the study will be published on October 14, 2008 in the World Journal of Gastroenterology. Thu, 23 Oct 2008 14:12:44 PST http://www.rxpgnews.com/hepatitis/Factors_for_developing_IPF_in_Hepatitis_C_patients_123817.shtml http://www.rxpgnews.com/research/Could-statins-be-a-new-option-for-hepatitis-C-patients_33310.shtml Latest Research WASHINGTON, D.C. (May 20, 2007) -- Research presented today at Digestive Disease Week? 2007 (DDW?) demonstrates the potential of statins, important cholesterol management therapies, for improving the management of hepatitis C ? a disease that affects nearly four million Americans. Although there have been no new treatments for hepatitis C since the introduction of pegylated interferon in 2001, the opportunity to develop a new generation of therapies that offer better outcomes may be imminent. DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Tue, 22 May 2007 10:00:00 PST http://www.rxpgnews.com/research/Could-statins-be-a-new-option-for-hepatitis-C-patients_33310.shtml http://www.rxpgnews.com/hepatitis/Chronic_hepatitis_in_pediatric_liver_transplant_pa_4227_4227.shtml Hepatitis A new study on the long-term outcome of children undergoing liver transplants found that chronic hepatitis (CH) was common and that it was not detectible using standard blood tests. The presence of autoantibodies (antibodies that attack the body's own tissues) in these patients indicates that although not fully understood, CH may be related to the immune response. Wed, 03 May 2006 01:22:00 PST http://www.rxpgnews.com/hepatitis/Chronic_hepatitis_in_pediatric_liver_transplant_pa_4227_4227.shtml http://www.rxpgnews.com/hepatitis/Vaccinating_Infants_of_Hepatitis_B_Mothers_Prevent_3321_3321.shtml Hepatitis Immunising newborn infants of mothers with hepatitis B prevents infection being transmitted from mother to child, finds a study published online by the BMJ. Tue, 31 Jan 2006 19:00:00 PST http://www.rxpgnews.com/hepatitis/Vaccinating_Infants_of_Hepatitis_B_Mothers_Prevent_3321_3321.shtml http://www.rxpgnews.com/hepatitis/Need_for_treatment_modification_in_older_hepatitis_3098_3098.shtml Hepatitis A new study in Japan examining the effects of combination therapy on older patients with hepatitis C found more adverse effects necessitating discontinuation of treatment, lowering of dosages, and lower long-term benefits in this age group. Fri, 06 Jan 2006 03:35:00 PST http://www.rxpgnews.com/hepatitis/Need_for_treatment_modification_in_older_hepatitis_3098_3098.shtml http://www.rxpgnews.com/hepatitis/Therapy_may_not_be_necessary_for_asymptomatic_auto_2074_2074.shtml Hepatitis It is not uncommon for patients with autoimmune hepatitis (AIH), a disease in which the patient's own immune system attacks the liver, to have no symptoms. Such cases are being diagnosed more frequently due to the increased practice of administering routine liver enzyme and antibody tests. Mon, 15 Aug 2005 21:08:00 PST http://www.rxpgnews.com/hepatitis/Therapy_may_not_be_necessary_for_asymptomatic_auto_2074_2074.shtml http://www.rxpgnews.com/hepatitis/PegInterferon-alfa-2b_with_Ribavirin_Shows_Promise_1342_1342.shtml Hepatitis More than half of 61 children infected with chronic hepatitis C achieved a sustained viral response after treatment with peginterferon-alfa-2b and ribavirin, report the authors of a new study published in the May 2005 issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD). Tue, 03 May 2005 13:26:00 PST http://www.rxpgnews.com/hepatitis/PegInterferon-alfa-2b_with_Ribavirin_Shows_Promise_1342_1342.shtml